BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34628271)

  • 1. Dosimetric effect of variable rectum and sigmoid colon filling during carbon ion radiotherapy to sacral chordoma.
    Ricotti R; Pella A; Mirandola A; Fiore MR; Chalaszczyk A; Paganelli C; Antonioli L; Vai A; Tagaste B; Belotti G; Rossi M; Ciocca M; Orlandi E; Baroni G
    Phys Med; 2021 Oct; 90():123-133. PubMed ID: 34628271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal dose-sparing effect with bioabsorbable spacer placement in carbon ion radiotherapy for sacral chordoma: dosimetric comparison of a simulation study.
    Shiba S; Okamoto M; Tashiro M; Ogawa H; Osone K; Yanagawa T; Kohama I; Okazaki S; Miyasaka Y; Osu N; Chikuda H; Saeki H; Ohno T
    J Radiat Res; 2021 May; 62(3):549-555. PubMed ID: 33783533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300).
    Russo S; Ricotti R; Molinelli S; Patti F; Barcellini A; Mastella E; Pella A; Paganelli C; Marvaso G; Pepa M; Comi S; Zaffaroni M; Avuzzi B; Giandini T; Pignoli E; Valdagni R; Baroni G; Cattani F; Ciocca M; Jereczek-Fossa BA; Orlandi E; Orecchia R; Vischioni B
    Front Oncol; 2021; 11():740661. PubMed ID: 34650922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
    Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
    Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfractional robustness of scanning carbon ion radiotherapy for prostate cancer: An analysis based on dose distribution from daily in-room CT images.
    Tsuchida K; Minohara S; Kusano Y; Kano K; Anno W; Takakusagi Y; Mizoguchi N; Serizawa I; Yoshida D; Imura K; Takayama Y; Kamada T; Katoh H; Ohno T
    J Appl Clin Med Phys; 2021 Jun; 22(6):130-138. PubMed ID: 34046997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
    Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial analysis of the dosimetric benefit and clinical resource cost of CBCT-based online adaptive radiotherapy for patients with cancers of the cervix or rectum.
    Yock AD; Ahmed M; Ayala-Peacock D; Chakravarthy AB; Price M
    J Appl Clin Med Phys; 2021 Oct; 22(10):210-221. PubMed ID: 34529332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer.
    Lebesque JV; Bruce AM; Kroes AP; Touw A; Shouman RT; van Herk M
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1109-19. PubMed ID: 7493837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon ion radiotherapy for sacral chordoma.
    Imai R; Kamada T; Sugahara S; Tsuji H; Tsujii H
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S48-54. PubMed ID: 21427182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer.
    Prabhakar R; Oates R; Jones D; Kron T; Cramb J; Foroudi F; Geso M; Gill S
    Med Dosim; 2014; 39(1):38-43. PubMed ID: 24412028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
    Eminowicz G; Rompokos V; Stacey C; Hall L; McCormack M
    Radiother Oncol; 2017 Jan; 122(1):116-121. PubMed ID: 27863962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma.
    Lorenzo C; Andrea P; Barbara V; Denis P; Rosaria FM; Piero F; Viviana V; Alberto I; Mario C; Brugnatelli S; Tommaso D; Bugada D; Marcello M; Mario A; Francesca V; Roberto O; Paolo D
    World J Surg Oncol; 2016 Aug; 14(1):211. PubMed ID: 27507254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation.
    Landry G; Nijhuis R; Dedes G; Handrack J; Thieke C; Janssens G; Orban de Xivry J; Reiner M; Kamp F; Wilkens JJ; Paganelli C; Riboldi M; Baroni G; Ganswindt U; Belka C; Parodi K
    Med Phys; 2015 Mar; 42(3):1354-66. PubMed ID: 25735290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric impact of different bladder and rectum filling during prostate cancer radiotherapy.
    Chen Z; Yang Z; Wang J; Hu W
    Radiat Oncol; 2016 Aug; 11():103. PubMed ID: 27485637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
    Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
    Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.